Underlying mechanism of combined effect of methamphetamine and morphine on lethality in mice and therapeutic potential of cooling

Journal of Pharmacological Sciences

Volumn 99, Issue 2, 2005, Pages 168-176

  Namiki, Mizuho ^a   Mori, Tomohisa ^a   Sawaguchi, Toshiko ^a   Ito, Shinobu ^a   Suzuki, Tadashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Methamphetamine; Morphine; Oxidative stress; Toxicity

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZAMIDE; DIZOCILPINE; HALOPERIDOL; METHAMPHETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COOLING; DRUG EFFECT; DRUG MECHANISM; LETHALITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN;

EID: 27344433824     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPJ05004X     Document Type: Article

References (40)

1. Ranaldi R, Wise RA. Intravenous self-administration of methamphetamine-heroin (speedball) combinations under a progressive-ratio schedule of reinforcement in rats. Neuroreport. 2000;11:2621-2623.
2. Kita T, Wagner GC, Nakashima T. Current research on methamphetamine- induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci. 2003;92:178-195.
3. Cadet JL, Jayanthi S, Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 2003;17:1775-1788.
4. Yamamoto BK, Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther. 1998;287:107-114.
5. Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98:7-22.
6. Suzuki T, Mori T, Tsuji M, Misawa M. Interaction between discriminative stimulus effects of cocaine and morphine. Jpn J Pharmacol. 1995;67:341-347.
7. Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M, et al. Differential effects of μ -, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur J Pharmacol. 1997;324:21-29.
8. Masukawa Y, Suzuki T, Misawa M. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology. 1993;111:139-143.
9. Spealman RD, Bergman J. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther. 1992;261:607-615.
10. Spealman RD, Bergman J. Opioid modulation of the discriminative stimulus effects of cocaine: comparison of micro, kappa and delta agonists in squirrel monkeys discriminating low doses of cocaine. Behav Pharmacol. 1994;5:21-31.
11. Leri F, Flores J, Rajabi H, Stewart J. Effects of cocaine in rats exposed to heroin. Neuropsychopharmacology. 2003;28:2102-2116.
12. Uemura K, Sorimachi Y, Yashiki M, Yoshida K. Two fatal cases involving concurrent use of methamphetamine and morphine. J Forensic Sci. 2003;48:1179-1181.
13. Funahashi M, Kohda H, Shikata I, Kimura H. Potentiation of lethality and increase in body temperature by combined use of d-methamphetamine and morphine in mice. Forensic Sci Int. 1988;37:19-26.
14. Mori T, Ito S, Narita M, Suzuki T, Sawaguchi T. Combined effects of psychostimulants and morphine on locomotor activity in mice. J Pharmacol Sci. 2004;96:450-458.
15. Mori T, Ito S, Kita T, Sawaguchi T. Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. J Pharmacol Sci. 2004;96:459-464.
16. Bristow LJ, Thorn L, Tricklebank MD, Hutson PH. Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice. Eur J Pharmacol. 1994;264:353-359.
17. Itzhak Y. Modulation of the PCP/NMDA receptor complex and sigma binding sites by psychostimulants. Neurotoxicol Teratol. 1994;16:363-368.
18. O'Shea E, Sanchez V, Camarero J, Green AR, Colado MI. On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor. Psychopharmacology. 2003;165:317-319.
19. Cosi C, Chopin P, Marien M. Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse. Brain Res. 1996;735:343-348.
20. Itzhak Y, Ali SF. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem. 1996;67:1770-1773.
21. Iwashita A, Mihara K, Yamazaki S, Matsuura S, Ishida J, Yamamoto H, et al. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5- quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice. J Pharmacol Exp Ther. 2004;310:1114-1124.
22. LaVoie MJ, Hastings TG. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci. 1999;19:1484-1491.
23. Huang HM, Shen CC, Ou HC, Yu JY, Chen HL, Kuo JS, et al. Neuroprotective MK801 is associated with nitric oxide synthase during hypoxia/reoxygenation in rat cortical cell cultures. J Cell Biochem. 2002;84:367-376.
24. Yan QS, Reith ME, Jobe PC, Dailey JW. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 1997;765:149-158.
25. Wedzony K, Mackowiak M, Zajaczkowski W, Fijal K, Chocyk A, Czyrak A. WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801. Neuropsychopharmacology. 2000;23:547-559.
26. Hanania T, McCreary AC, Haughey HM, Salaz DO, Zahniser NR. MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems. Eur J Pharmacol. 2002;457:125-135.
27. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613-622.
28. Davidson EA, Bustamante MM, de Siqueira Pinto A. Emissions of nitrous oxide and nitric oxide from soils of native and exotic ecosystems of the Amazon and Cerrado regions of Brazil. Scientific World Journal. 2001;1 Suppl 2:312-319.
29. Cosi C, Suzuki H, Milani D, Facci L, Menegazzi M, Vantini G, et al. Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res. 1994;39:38-46.
30. Sheng P, Cerruti C, Cadet JL. Methamphetamine (METH) causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide. Life Sci. 1994;55:51-54.
31. Seiden LS, Sabol KE. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr. 1996;163:251-276.
32. Pieper AA, Verma A, Zhang J, Snyder SH. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci. 1999;20:171-181.
33. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF, Holson RR. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther. 1992;260:817-824.
34. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr, et al. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther. 1994;268:1571-1580.
35. Sonsalla PK, Gibb JW, Hanson GR. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther. 1986;238:932-937.
36. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biologic messenger. Cell. 1992;70:705-707.
37. Di Monte DA, Royland JE, Jakowec MW, Langston JW. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem. 1996;67:2443-2450.
38. Itzhak Y, Gandia C, Huang PL, Ali SF. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther. 1998;284:1040-1047.
39. Culcasi M, Lafon-Cazal M, Pietri S, Bockaert J. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J Biol Chem. 1994;269:12589-12593.
40. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 1993;364:535-537.